18% Y-o-Y growth in revenue & 9.4 % in profit
|Particulars||Figures in||FY18||Q4 FY18||FY17||
|Op. EBITDA||INR Mn||3,065||905||2,622||690||16.9%|
|Net Profit||INR Mn||1,599||455||1,462||418||9.4%|
Chennai, May 17 2018: TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences, today announced its financial results for Q4 and year ended FY18. The company reported FY18 revenues of INR Mn 15,872 a 18% growth over the previous year.
Key highlights over the year:
- Strong growth in Life Sciences 3% Y-o-Y and 8.37% CQGR over last 12 quarters
- Flagship product pharmaReady has surpassed its milestone of 150 customers
- Recognized as
- A ‘Leader’ in the IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment
- ‘Best Employer Brand’ for the second consecutive year and ranked 3rd in the ‘Times Ascent presents Dream Companies to Work For’ category at the World HRD Congress
Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions said, “Financial year 2018 has been a positive year for TAKE Solutions with continued strong performance in life sciences business in terms of profitability, customer track record and recognition. Looking ahead, we have a healthy pipeline of new business opportunities in India and we plan to carry this momentum through the year. We are keen to pursue strategic acquisitions in North America and Europe, funded by our recent preferential allotment of shares, to capitalize on our opportunities and scale our business in the high-growth Clinical and Regulatory spaces.”
For more information on our earnings release, please visit: http://www.takesolutions.com/images/financial/take_solutions_q4_fy18_earnings_release.pdf
About TAKE Solutions Limited
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.
In the fast-growing Life Sciences space, TAKE offers clients a unique combination of a full-service CRO backed by industry insights and technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through our proprietary industry networks. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers outcomes for clients, including 9 of the top 10 global pharmaceutical companies.
In Supply Chain Management, TAKE focuses on high-margin niches in engineering, mobility and collaboration. Our IP-led approach enables our clients to automate supply chain processes, track, trace & control at item level, extend mobility, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes.
With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY17 revenues touching INR 13,520 Mn, a 29% increase year-on-year.
For more details, please visit www.takesolutions.com
For media information: